Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …
Read More »Tesla share shot higher through Upgrades from BofA and Morgan Stanley
Analysts at BofA Securities and Morgan Stanley upgraded their ratings on Tesla Inc. shares on Friday, tinning the ranks of Tesla bears and increasing the stock to another record. Tesla TSLA, + 1.98% stock is on Friday for another very high, and has almost doubled in price this year. Earlier …
Read More »Modern stockrally disappears as analysts weigh on what US government deal means for COVID-19 vaccine prices
The rally in shares in Moderna Inc. jumped through news late Tuesday that the U.S. government ordered 100 million doses of its COVID-19 vaccine candidate on Wednesday as analysts waited for what the order meant for prices. Modern MRNA, + 1.94% is widely regarded as a front-runner in the race …
Read More »